National long COVID impact and risk factors
- PMID: 36434908
- PMCID: PMC9683693
- DOI: 10.1016/j.puhe.2022.09.021
National long COVID impact and risk factors
Abstract
Objective: Our objective was to estimate the prevalence and risk factors for long COVID symptoms among polymerase chain reaction-confirmed COVID-19 patients (hospitalised and community) in Malta.
Study design: This was a national cross-sectional survey among COVID-19 patients in Malta during 2020.
Methods: Patients were sent a questionnaire 3-6 months after testing positive. Data were analysed descriptively to estimate symptom prevalence, and multivariable logistic regressions were used to determine the risk factors for long COVID symptoms. Age, sex, initial symptoms, hospitalisation, and healthcare worker status were used as risk factors and symptoms (cough, shortness of breath, fatigue, anxiety, sadness, and memory loss) 2.5 months or more after COVID-19 onset were used as outcomes.
Results: Of 8446 eligible participants, 2665 (31.55%) responded with a median age of 37 years. Initial symptoms were reported in 82% of responders, and 7.73% were hospitalised. Among the long COVID symptoms, fatigue persisted among most non-hospitalised responders, whereas anxiety, shortness of breath, and sadness were the most common symptoms. Female sex, hospitalisation, and initial symptoms were associated with higher odds of fatigue, shortness of breath, cough, anxiety, sadness, and memory loss as long COVID symptoms.
Conclusions: Our study is the first to highlight long COVID symptoms and risk factors in Malta, showing that long COVID is common among hospitalised and non-hospitalised patients. These data should increase awareness of long COVID and facilitate support to those affected nationally.
Keywords: COVID-19 infection; Cross-sectional survey; Long COVID.
Copyright © 2022 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
None declared.
Figures
Similar articles
-
Associations Between Acute COVID-19 Symptom Profiles and Long COVID Prevalence: Population-Based Cross-Sectional Study.JMIR Public Health Surveill. 2024 Oct 1;10:e55697. doi: 10.2196/55697. JMIR Public Health Surveill. 2024. PMID: 39352725 Free PMC article.
-
A glimpse into Long COVID characteristics and the mental health impact within a highly vaccinated population: a Malta observational study.Ann Ist Super Sanita. 2023 Apr-Jun;59(2):101-107. doi: 10.4415/ANN_23_02_02. Ann Ist Super Sanita. 2023. PMID: 37337984
-
Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study.Public Health. 2023 Mar;216:39-44. doi: 10.1016/j.puhe.2023.01.008. Epub 2023 Feb 13. Public Health. 2023. PMID: 36791649
-
"LONG COVID": an insight.Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5561-5577. doi: 10.26355/eurrev_202109_26669. Eur Rev Med Pharmacol Sci. 2021. PMID: 34533807
-
[Long lasting symptoms of dyspnea, cough and fatigue after COVID-19 - narrative review of epidemiological studies].Med Pr. 2021 Dec 22;72(6):711-720. doi: 10.13075/mp.5893.01190. Epub 2021 Dec 1. Med Pr. 2021. PMID: 34850782 Review. Polish.
Cited by
-
Clinical Features and Risk Factors of Post-COVID-19 Condition in Korea.J Prev Med Public Health. 2023 Sep;56(5):431-439. doi: 10.3961/jpmph.23.124. Epub 2023 Sep 8. J Prev Med Public Health. 2023. PMID: 37735829 Free PMC article.
-
Sex Differences in Long COVID.JAMA Netw Open. 2025 Jan 2;8(1):e2455430. doi: 10.1001/jamanetworkopen.2024.55430. JAMA Netw Open. 2025. PMID: 39841477 Free PMC article.
-
Incidence and risk factors of post COVID-19 syndrome: a Tunisian cohort study.BMC Infect Dis. 2024 May 1;24(1):461. doi: 10.1186/s12879-023-08949-8. BMC Infect Dis. 2024. PMID: 38693500 Free PMC article.
-
The Factors Influencing the Incidence, Persistence, and Severity of Symptoms After SARS-CoV-2 Infection in Chinese Adults: A Case-Control Study.Trop Med Infect Dis. 2025 Jun 30;10(7):185. doi: 10.3390/tropicalmed10070185. Trop Med Infect Dis. 2025. PMID: 40711062 Free PMC article.
-
Prospective cohort study of fatigue before and after SARS-CoV-2 infection in the Netherlands.Nat Commun. 2025 Mar 4;16(1):1923. doi: 10.1038/s41467-025-56994-5. Nat Commun. 2025. PMID: 40038286 Free PMC article.
References
-
- World Health Organization . WHO; 2020. A clinical case definition of post COVID-19 condition by a Delphi consensus.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical